Results of 2 new LDN clinical trials are now available: 

 1) Stanford University (USA)

reported on LDN’s ability to

significantly reduce pain

and depression among

patients

with chronic pain. 

Click here to read more on the chronic pain study.

 2) Erasmus University (Netherlands)

presented LDN’s potential

benefit in treatment

of IBD (Crohn’s

Disease

and Ulcerative Colitis). 

Click here to read more on the IBD study.

From:

The LDNscience^® Team